1-4 of 4
Jessica van Ziffle
Close
Sort by
Journal Articles

Risk Stratified Treatment for Patients with Newly Diagnosed Juvenile Myelomonocytic Leukemia: A Phase 1/2 Non-Randomized Study of Trametinib and Azacitidine with or without Chemotherapy

Elliot Stieglitz, Yueh-Yun Chi, Bill H. Chang, Sarah K. Tasian, Marielle Yohe, Christopher C Dvorak, Erica Southworth, Janel R. Long-Boyle, Jessica Van Ziffle, Zied Abdullaev, Roy Leong, Alan S. Wayne, Deepa Bhojwani, Mignon L. Loh
Journal: Blood
Blood (2023) 142 (Supplement 1): 3210.
https://doi.org/10.1182/blood-2023-177838
Published: 2023
Journal Articles

The Role of Comprehensive Mutational Profiling in Predicting Patients Who May Benefit from Autologous Hematopoietic Cell Transplant for Acute Myeloid Leukemia

Gabriel N. Mannis, MD, Nicole Therrien, Jessica Van Ziffle, Nicole Foley, Iwei Yeh, Shan Zhong, PhD, Jie He, PhD, Michelle Nahas, PhD, Charalambos Andreadis, MD MSCE, Lloyd E. Damon, MD, Rebecca L. Olin, MD MS, Sonam Prakash, MD, Tariq I Mughal, MD FRCP, Aaron C. Logan, MDPhDMPhil, Thomas G. Martin, III, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1423.
https://doi.org/10.1182/blood.V130.Suppl_1.1423.1423
Published: 2017
Journal Articles

Biochemical and Functional Analysis of Novel KRAS Insertions in MPN and Other Cancers

Yasmine N White, Aditi Bagchi, Jessica Van Ziffle, PhD, Gideon Bollag, PhD, Chao Zhang, PhD, David S Dickens, MD, Mignon L. Loh, MD, Kevin Shannon, MD, Ari J Firestone, PhD
Journal: Blood
Blood (2014) 124 (21): 2207.
https://doi.org/10.1182/blood.V124.21.2207.2207
Published: 2014
Journal Articles

Anemia and Ineffective Erythropoiesis Caused by Somatic RAS Mutation.

Benjamin S. Braun, MD, PhD, Jessica van Ziffle, Joehleen Gavin, David A. Tuveson, MD, PhD, Tyler Jacks, PhD, Kevin Shannon, MD
Journal: Blood
Blood (2004) 104 (11): 3419.
https://doi.org/10.1182/blood.V104.11.3419.3419
Published: 2004